Records containing: Takayasu Arteritis (TAK)
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-03-05A Prospective, Open-label, Controlled, Multiple Centers Clinical Study of the Efficacy and Safety for Vunakizumab and Ivarmacitinib in the Treatment of Active Takayasu's Arteritis (TAK): The VIVA-TAK Ttrial
-
CLINICAL_TRIALS study record update · 2026-02-18A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Upadacitinib in Subjects With Takayasu Arteritis (SELECT-Takayasu)
-
CLINICAL_TRIALS study record update · 2026-01-23The Vasculitis Pregnancy Registry (V-PREG)
-
CLINICAL_TRIALS study record update · 2026-01-20Investigating Management, Perspectives and Attitudes Towards Care in Takayasu Arteritis
-
CLINICAL_TRIALS study record update · 2025-06-10Comparison of Deucravacitinib and Adalimumab for the Treatment of Relapsed Takayasu's Arteritis: The TYK-TAK Trial
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-02-04Evaluation of Platelet Aggregability in Patients with Takayasu's Arteritis
-
CLINICAL_TRIALS study record update · 2025-01-09A Multicenter Registry Study Assessing Patient Reported Outcome, Dosing Patterns, and Safety of Vunakizumab in Patients With General Rheumatic Diseases.